Familial erythrocytosis is an inherited condition characterized by an increased number of red blood cells (erythrocytes). The primary function of these cells is ...

... the EPAS1 gene have been found to cause familial erythrocytosis, an inherited condition characterized by an increased number ... an elevated risk of abnormal blood clots. When familial erythrocytosis results from EPAS1 gene mutations, it is often ...

... the EGLN1 gene have been found to cause familial erythrocytosis, an inherited condition characterized by an increased number ... an elevated risk of abnormal blood clots. When familial erythrocytosis results from EGLN1 gene mutations, it is often ...

... the VHL gene have been found to cause familial erythrocytosis, a condition characterized by an increased number of ... an elevated risk of abnormal blood clots. When familial erythrocytosis results from VHL gene mutations, it is often ...

... the EPOR gene have been found to cause familial erythrocytosis, an inherited condition characterized by an increased number ... an elevated risk of abnormal blood clots. When familial erythrocytosis results from EPOR gene mutations, it is often ...

... to run in families. In some of these families, the risk of developing polycythemia vera appears to have an autosomal dominant pattern ... condition in familial cases is unknown. In these families, people seem to inherit an increased risk of ... itself. Osler-Vaquez disease ...

... not show signs and symptoms of the condition. Familial manganese-induced neurotoxicity HMNDYT Genetic Testing Registry: Hypermanganesemia with dystonia 2 Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome National Organization for Rare Disorders (NORD) ...

... so excess amounts of this element may underlie polycythemia. More About This Health Condition DKFZp547M236 HMDPC solute carrier family 30, member 10 zinc transporter 10 ZnT-10 ...

... mutations in the TET2 gene are associated with polycythemia vera, a disorder characterized by uncontrolled blood cell ... found in approximately 16 percent of people with polycythemia vera. It is unclear what role these mutations ...